Zhang Yi
Plus aucun poste en cours
Profil
Zhang Yi is the founder of Epizyme, Inc. which was founded in 2007.
Mr. Yi also worked as Vice Chairman at Datang International Power Generation Co., Ltd.
Anciens postes connus de Zhang Yi
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Fondateur | - |
| DATANG INTERNATIONAL POWER GENERATION CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DATANG INTERNATIONAL POWER GENERATION CO., LTD. | Utilities |
| Entreprise privées | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
